31 results on '"Sozzi, Vitina"'
Search Results
2. SAT-377 CRISPR-Cas13b-mediated suppression of hepatitis B surface antigen-pre-clinical investigations of a new therapeutic approach
3. Clinical stage drugs targeting inhibitor of apoptosis proteins purge episomal Hepatitis B viral genome in preclinical models
4. Hepatitis B Surface Expression is Up-Regulated by HIV Tat Protein in Co-Infected Hepatocytes with Significant Transcriptomic Changes Favouring Adverse Liver Outcomes
5. Hepatitis B virus haplotype number at baseline is a predictive marker of functional cure during antiviral therapy for patients with genotypes A and D HBeAg ‐positive chronic hepatitis B
6. Hepatitis B virus splice variants are associated with reduced likelihood of functional cure and differ across phases of chronic hepatitis B infection
7. Deep sequencing shows that HBV basal core promoter and precore variants reduce the likelihood of HBsAg loss following tenofovir disoproxil fumarate therapy in HBeAg-positive chronic hepatitis B
8. Hepatitis B virus haplotype number at baseline is a predictive marker of functional cure during antiviral therapy for patients with genotypes A and D HBeAg‐positive chronic hepatitis B.
9. Secreted Hepatitis B virus splice variants differ by HBV genotype and across phases of chronic hepatitis B infection
10. Infection courses, virological features and IFN-α responses of HBV genotypes in cell culture and animal models
11. Hepatitis B virus genotype C encoding resistance mutations that emerge during adefovir dipivoxil therapy: in vitro replication phenotype
12. Analysis of Hepatitis B Virus Haplotype Diversity Detects Striking Sequence Conservation Across Genotypes and Chronic Disease Phase
13. Hepatitis B Virus (Hbv) Splice Variants are Associated with Reduced Likelihood of Functional Cure and Differ Across Phases of Chronic Hepatitis B Infection
14. Quantitative analysis of the splice variants expressed by the major hepatitis B virus genotypes
15. Quantitative analysis of the splice variants expressed by the major hepatitis B virus genotypes
16. Analysis of HBV full-genome haplotypes from immune tolerant-, immune clearance-, and immune resolution phase of chronic hepatitis B virus disease
17. Towards Genotype-Specific Care for Chronic Hepatitis B: The First 6 Years Follow Up From the CHARM Cohort Study
18. FRI-194-The novel antiviral agent inarigivir inhibits both nucleos (t)ide analogue and capsid assembly inhibitor resistant HBV in vitro
19. Molecular characterization of hepatitis B virus (HBV) in African children living in Australia identifies genotypes and variants associated with poor clinical outcome
20. In vitro studies identify a low replication phenotype for hepatitis B virus genotype H generally associated with occult HBV and less severe liver disease
21. Hepatitis B virus sensitivity to interferon‐α in hepatocytes is more associated with cellular interferon response than with viral genotype
22. The in vitro replication phenotype of hepatitis B virus (HBV) splice variants Sp3 and Sp9 and their impact on wild-type HBV replication.
23. In Vitro Studies Show that Sequence Variability Contributes to Marked Variation in Hepatitis B Virus Replication, Protein Expression, and Function Observed across Genotypes
24. Deep sequencing shows that HBV basal core promoter and precore variants reduce the likelihood of HBsAg loss following tenofovir disoproxil fumarate therapy in HBeAg-positive chronic hepatitis B
25. Hepatitis B virus genotype C encoding resistance mutations that emerge during adefovir dipivoxil therapy: in vitro replication phenotype
26. Protease-activated receptors mediate apamin-sensitive relaxation of mouse and guinea pig gastrointestinal smooth muscle
27. Ischaemia/Reperfusion Enhances Phenylephrine-Induced Contraction of Rabbit Aorta Due to Impairment of Neuronal Uptake
28. 1162 LY582563 (MCC-478), a 2-aminopurine nucleotide analogue, inhibits packaging and replication of HBV genome in vitro
29. 1157 2′,3′-dideoxy-3′-fluoroguanosine (FLG) has antiviral activity against both wild type and lamivudine resistant hepatitis B virus in vitro: results of assays using the recombinant baculovirus system
30. 1139 Characterisation and functional analysis of hepatitis B virus mutants selected in patients with severe hepatitis during long term lamivudine therapy: role of compensatory mutations in disease progression
31. THU327 - Analysis of HBV full-genome haplotypes from immune tolerant-, immune clearance-, and immune resolution phase of chronic hepatitis B virus disease.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.